Nebraska Cancer Specialists- Midwest Cancer Center- Papillion

611 Fenwick Drive
Papillion, Nebraska 68046

We've found

1 trials

at this facility

ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Papillion, NE

Use our guide to learn which trials are right for you!